Language

Medicine shortages: Belgium · Page 8

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 8 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 8

Belgium

Lasix 40 mg tabl. 50

Nicht verfügbar · Delay in final product release
Active ingredient: Furosemide

Notice details →
Belgium

Lipitor 80 mg film-coat. tabl. 98

Nicht verfügbar · Delay in final product release
Active ingredient: Atorvastatin

Notice details →
Belgium

Naropin 2 mg/ml inj. sol. epidur. amp. 5 x 20 ml

Nicht verfügbar · Increased demand
Active ingredient: Ropivacaine Hydrochloride

Notice details →
Belgium

Olmesartan/Amlodipin/HCT Viatris 40 mg - 10 mg - 25 mg film-coat. tabl. 98

Available again · Not specified
Active ingredient: Olmesartan Medoxomil,Amlodipine,Hydrochlorothiazide

Notice details →
Belgium

Pamidronate Disodium Hospira 6 mg/ml inf. sol. (conc.) i.v. vial 10 ml

Available again · Not specified
Active ingredient: Pamidronic Acid

Notice details →
Belgium

Paracetamol Sandoz 1 g efferv. tabl. 32

Nicht verfügbar · Manufacturing delay
Active ingredient: Paracetamol

Notice details →
Belgium

Quetiapin Sandoz 100 mg film-coat. tabl. 30

Available again · Not specified
Active ingredient: Quetiapine

Notice details →
Belgium

Quetiapin Sandoz 25 mg film-coat. tabl. 60

Available again · Not specified
Active ingredient: Quetiapine

Notice details →
Belgium

Rifadine 150 mg hard caps. 100

Available again · Not specified
Active ingredient: Rifampicin

Notice details →
Belgium

Rivaroxaban Sandoz 15 mg film-coat. tabl. 42 (42 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Rivaroxaban

Notice details →
Belgium

Rivaroxaban Sandoz 2.5 mg film-coat. tabl. 56 (56 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Rivaroxaban

Notice details →
Belgium

Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UD

Nicht verfügbar · Sonstige
Active ingredient: Solifenacin ,Tamsulosin

Notice details →
Belgium

Sumatriptan EG 100 mg tabl. 24

Nicht verfügbar · Manufacturing delay
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan EG 100 mg tabl. 6

Nicht verfügbar · Increased demand
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan EG 50 mg tabl. 12

Nicht verfügbar · Increased demand
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan EG 50 mg tabl. 24

Nicht verfügbar · Manufacturing delay
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan EG 50 mg tabl. 6

Nicht verfügbar · Manufacturing delay
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan Viatris 100 mg film-coat. tabl. 12

Nicht verfügbar · Sonstige
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan Viatris 100 mg film-coat. tabl. 24

Nicht verfügbar · Sonstige
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan Viatris 100 mg film-coat. tabl. 48

Nicht verfügbar · Sonstige
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan Viatris 50 mg film-coat. tabl. 12

Nicht verfügbar · Sonstige
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan Viatris 50 mg film-coat. tabl. 24

Nicht verfügbar · Sonstige
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan Viatris 50 mg film-coat. tabl. 48

Nicht verfügbar · Sonstige
Active ingredient: Sumatriptan

Notice details →
Belgium

Sumatriptan Viatris 50 mg film-coat. tabl. 6

Nicht verfügbar · Sonstige
Active ingredient: Sumatriptan

Notice details →
Belgium

Xolair 150 mg inj. sol. s.c. pre-filled syr. 6 x 1 ml

Available again · Not specified
Active ingredient: Omalizumab

Notice details →
Belgium

Yesintek 45 mg inj. sol. s.c. pre-filled pen 0.5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Ustekinumab

Notice details →
Belgium

Adempas 2.5 mg film-coat. tabl. 42

Available again · Not specified
Active ingredient: Riociguat

Notice details →
Belgium

Amoxicillin AB 500 mg film-coat. tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Amoxicillin

Notice details →
Belgium

Cedur 200 mg coat. tabl. 60

Nicht verfügbar · Sonstige
Active ingredient: Bezafibrate

Notice details →
Belgium

Dimethyl Fumarate Teva 240 mg hard gastro-resist. caps. 56 (56 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Dimethyl Fumarate

Notice details →
Belgium

Emthexate 50 mg/2 ml inj. sol. i.m./i.thec./i.ventricul./i.v./i.arter. vial 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Methotrexate

Notice details →
Belgium

Etoricoxib AB 120 mg film-coat. tabl. 7

Nicht verfügbar · Sonstige
Active ingredient: Etoricoxib

Notice details →
Belgium

Etoricoxib AB 30 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Etoricoxib

Notice details →
Belgium

Etoricoxib AB 60 mg film-coat. tabl. 7

Nicht verfügbar · Sonstige
Active ingredient: Etoricoxib

Notice details →
Belgium

Etoricoxib AB 60 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Etoricoxib

Notice details →
Belgium

Eulitop 400 mg tabl. prol.-rel. 30

Nicht verfügbar · Sonstige
Active ingredient: Bezafibrate

Notice details →
Belgium

Febuxostat AB 80 mg film-coat. tabl. 84

Nicht verfügbar · Sonstige
Active ingredient: Febuxostat

Notice details →
Belgium

Fucithalmic 10 mg/g eye gel 5 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Fusidic Acid

Notice details →
Belgium

Glazidim 1 g inj./inf. sol. (pwdr.) i.m./i.v. vial 1000 mg

Nicht verfügbar · Manufacturing delay
Active ingredient: Ceftazidime

Notice details →
Belgium

Levobupivacaïne Fresenius Kabi 7.5 mg/ml inj./inf. sol. i.thec./epidur. amp. 5 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Levobupivacaine

Notice details →
Belgium

Levocetirizin AB 5 mg film-coat. tabl. 100

Nicht verfügbar · Sonstige
Active ingredient: Levocetirizine

Notice details →
Belgium

Litican 50 mg/2 ml inj. sol. i.m./i.v. amp. 6 x 2 ml

Marketing ended · Commercial reasons
Active ingredient: Alizapride

Notice details →
Belgium

Litican 50 mg tabl. 20 (20 x 1) UD

Marketing ended · Commercial reasons
Active ingredient: Alizapride

Notice details →
Belgium

Litican 50 mg tabl. 20

Marketing ended · Commercial reasons
Active ingredient: Alizapride

Notice details →
Belgium

Lonquex 6 mg/0.6 ml inj. sol. s.c. vial 6 x 0.6 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Lipegfilgrastim

Notice details →
Belgium

Medrol 32 mg tabl. 20

Nicht verfügbar · Increased demand
Active ingredient: Methylprednisolone

Notice details →
Belgium

Midazolam Viatris 1 mg/ml inj. sol. i.m./i.v. amp. 10 x 5 ml

Nicht verfügbar · Sonstige
Active ingredient: Midazolam

Notice details →
Belgium

Neurontin 600 mg film-coat. tabl. 90

Available again · Not specified
Active ingredient: Gabapentin

Notice details →
Belgium

Nifedipine Retard EG 60 mg tabl. prol.-rel. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Nifedipine

Notice details →
Belgium

Paracetamol AB 1 000 mg tabl. 100

Nicht verfügbar · Sonstige
Active ingredient: Paracetamol

Notice details →